275 related articles for article (PubMed ID: 3700610)
1. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
Clements ML; Murphy BR
J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
[TBL] [Abstract][Full Text] [Related]
2. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
Powers DC; Sears SD; Murphy BR; Thumar B; Clements ML
J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535
[TBL] [Abstract][Full Text] [Related]
3. Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.
Gorse GJ; Belshe RB; Munn NJ
J Clin Microbiol; 1988 May; 26(5):911-8. PubMed ID: 3384914
[TBL] [Abstract][Full Text] [Related]
4. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML
J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
[TBL] [Abstract][Full Text] [Related]
5. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.
Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
J Med Virol; 1985 Dec; 17(4):325-35. PubMed ID: 4078559
[TBL] [Abstract][Full Text] [Related]
6. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.
Murphy BR; Nelson DL; Wright PF; Tierney EL; Phelan MA; Chanock RM
Infect Immun; 1982 Jun; 36(3):1102-8. PubMed ID: 7095844
[TBL] [Abstract][Full Text] [Related]
7. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
Gorse GJ; Belshe RB; Munn NJ
J Clin Microbiol; 1986 Sep; 24(3):336-42. PubMed ID: 3531226
[TBL] [Abstract][Full Text] [Related]
8. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.
Clements ML; Betts RF; Tierney EL; Murphy BR
J Clin Microbiol; 1986 Jul; 24(1):157-60. PubMed ID: 3722363
[TBL] [Abstract][Full Text] [Related]
9. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
[TBL] [Abstract][Full Text] [Related]
10. Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.
Chen KS; Burlington DB; Quinnan GV
J Virol; 1987 Jul; 61(7):2150-4. PubMed ID: 3586130
[TBL] [Abstract][Full Text] [Related]
11. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly.
Gorse GJ; Otto EE; Powers DC; Chambers GW; Eickhoff CS; Newman FK
J Infect Dis; 1996 Feb; 173(2):285-90. PubMed ID: 8568287
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
[TBL] [Abstract][Full Text] [Related]
13. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.
Wagner DK; Clements ML; Reimer CB; Snyder M; Nelson DL; Murphy BR
J Clin Microbiol; 1987 Mar; 25(3):559-62. PubMed ID: 3571460
[TBL] [Abstract][Full Text] [Related]
14. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML
J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
[TBL] [Abstract][Full Text] [Related]
15. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
Ainai A; van Riet E; Ito R; Ikeda K; Senchi K; Suzuki T; Tamura SI; Asanuma H; Odagiri T; Tashiro M; Kurata T; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
Microbiol Immunol; 2020 Apr; 64(4):313-325. PubMed ID: 31957054
[TBL] [Abstract][Full Text] [Related]
16. Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine.
Zahradnik JM; Kasel JA; Martin RR; Six HR; Cate TR
J Med Virol; 1983; 11(4):277-85. PubMed ID: 6875521
[TBL] [Abstract][Full Text] [Related]
17. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
Treanor JJ; Roth FK; Betts RF
J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
[TBL] [Abstract][Full Text] [Related]
18. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
Manenti A; Tete SM; Mohn KG; Jul-Larsen Å; Gianchecchi E; Montomoli E; Brokstad KA; Cox RJ
Vaccine; 2017 Jan; 35(1):191-198. PubMed ID: 27789145
[TBL] [Abstract][Full Text] [Related]
20. Secretory immunological response after intranasal inactivated influenza A virus vaccinations: evidence for immunoglobulin A memory.
Wright PF; Murphy BR; Kervina M; Lawrence EM; Phelan MA; Karzon DT
Infect Immun; 1983 Jun; 40(3):1092-5. PubMed ID: 6852914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
